Following with the mentioned study, our study showed that the SPAP in the patient group was approximately 1.7 times that of the control group, indicating the presence of pulmonary hypertension in a significant proportion of SSc patients. This evidence concerns the gene PDZK1IP1 and pulmonary arterial hypertension.